John Fox, MD

Clinical Focus

• Acute Coronary Syndrome
• Angiography
• Cardiac Catherization
• Cardiovascular Disease
• Heart Attack/Acute Coronary Syndrome
• Transcatheter Aortic Valve Replacement (TAVR)

• Acute Coronary Syndrome
• Angiography
• Cardiac Catherization
• Cardiovascular Disease
• Heart Attack/Acute Coronary Syndrome
• Transcatheter Aortic Valve Replacement (TAVR)

Research

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:12

Article:22

Review Article:1

Comment/Debate:1

Letter:1

Recent Artifacts

• Effect of Sex Difference on Discordance Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve
• ST-segment Elevation Myocardial Infarction Resulting from Stent Thrombosis in Contemporary Real-World Practice
• STEMI notification by EMS predicts shorter door-to-balloon time and smaller infarct size
• Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients with Non-ST-Segment Elevation Myocardial Infarction
• Predictive Value of ST-Segment Elevation in Lead aVR for Left Main and/or Three-Vessel Disease in Non-ST-Segment Elevation Myocardial Infarction
• Does mean platelet volume predict the location of the infarct-related artery in non-ST-segment elevation myocardial infarction patients?
• Association between preinfarction angina and angiographic findings in non-ST-segment elevation myocardial infarction
• Neutrophil-to-lymphocyte ratio as an independent predictor of left main and/or three-vessel disease in patients with non-ST-segment elevation myocardial infarction
• Prevalence and outcomes of non-ST-segment elevation myocardial infarction resulting from stent thrombosis
• Absence of ST-segment elevation in lead V1 predicts worse long-term outcomes in patients with first anterior ST-segment elevation myocardial infarction

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Fox during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.